相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Hybrid closed Loop improved glucose control compared to sensor-augmented pumps in outpatients with type 1 diabetes in real-life conditions with telehealth monitoring
C. Thivolet et al.
ACTA DIABETOLOGICA (2022)
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes
Anders L. Carlson et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2022)
Cost-Effectiveness Analysis of an Advanced Hybrid Closed-Loop Insulin Delivery System in People with Type 1 Diabetes in Greece
Vaia Lambadiari et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2022)
Improved technology satisfaction and sleep quality with Medtronic MiniMed® Advanced Hybrid Closed-Loop delivery compared to predictive low glucose suspend in people with Type 1 Diabetes in a randomized crossover trial
Benjamin J. Wheeler et al.
ACTA DIABETOLOGICA (2022)
Real-World Performance of the MiniMed™ 780G System: First Report of Outcomes from 4120 Users
Julien Da Silva et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2022)
Minimed Medtronic 780G optimizes glucose control in patients with type 1 diabetes mellitus
Basilio Pintaudi et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2022)
Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI)
Goran Petrovski et al.
BMC ENDOCRINE DISORDERS (2022)
Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control
Giuseppe Lepore et al.
ACTA DIABETOLOGICA (2022)
A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial
Richard M Bergenstal et al.
LANCET (2021)
Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes
Olivia J. Collyns et al.
DIABETES CARE (2021)
One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology
Marc D. Breton et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2021)
Rapid Improvement in Time in Range After the Implementation of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes
Pilar Isabel Beato-Vibora et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2021)
The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: a Health Economic Analysis in Sweden
Johan Jendle et al.
DIABETES THERAPY (2021)
Amelioration of user experiences and glycaemic outcomes with an Advanced Hybrid Closed Loop System in a real-world clinical setting
Pilar Isabel Beato-Vibora et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2021)
Lived Experience of Advanced Hybrid Closed-Loop Versus Hybrid Closed-Loop: Patient-Reported Outcomes and Perspectives
Korey K. Hood et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2021)
MiniMedTM780G Insulin pump system with smartphone connectivity for the treatment of type 1 diabetes: overview of its safety and efficacy
Jennifer McVean et al.
EXPERT REVIEW OF MEDICAL DEVICES (2021)
Review of automated insulin delivery systems for individuals with type 1 diabetes: tailored solutions for subpopulations
M. Eleonora Aiello et al.
CURRENT OPINION IN BIOMEDICAL ENGINEERING (2021)
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino et al.
DIABETES CARE (2019)